Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluviral vs Fluzone in Adults ≥ 50 Years
NCT00232947Phase 3Completed
- Sponsor
- ID Biomedical Corporation
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza a (h1n1) 2009 pandemic monovalent vaccine (without adjuvant) in influenza, sponsored by ID Biomedical Corporation. Started Oct 2005; status: completed.
02
Drugs
influenza a (h1n1) 2009 pandemic monovalent vaccine (without adjuvant)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00232947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232947.